Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection.
- DOI
- 10.3389/fimmu.2026.1828107
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1828107,
title = {Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection.},
author = {Kang SY and Yoo JR and Bae E and Kim J and Park Y and Kim M and Kim M and Ro HJ and Hwang D and Lee JY and Cho D and Nguyen HC and Hallam HJ and Heo ST and Cho NH and Lee KM and Letizia AG and Lee KH},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1828107},
url = {https://doi.org/10.3389/fimmu.2026.1828107}
}RIS
TY - JOUR TI - Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection. AU - Kang SY AU - Yoo JR AU - Bae E AU - Kim J AU - Park Y AU - Kim M AU - Kim M AU - Ro HJ AU - Hwang D AU - Lee JY AU - Cho D AU - Nguyen HC AU - Hallam HJ AU - Heo ST AU - Cho NH AU - Lee KM AU - Letizia AG AU - Lee KH PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1828107 UR - https://doi.org/10.3389/fimmu.2026.1828107 ER -
APA
SY, K., JR, Y., E, B., J, K., Y, P., M, K., M, K., HJ, R., D, H., JY, L., D, C., HC, N., HJ, H., ST, H., NH, C., KM, L., AG, L., & KH, L. (2026). Antibodies against interleukin-10 receptor reduce IL-6 and TNF-α levels and increase TGF-β levels in patients with severe fever with thrombocytopenia syndrome virus and SARS-CoV-2 infection.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1828107
Source records
- pubmed · retrieved 2026-09-25T09:27:50.280Z